Cargando…

Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease

Endothelin-1 (ET-1) and plasminogen activator inhibitor-1 (PAI-1) play important roles in pulmonary hypertension (PH) in sickle cell disease (SCD). Our previous studies show higher levels of placenta growth factor (PlGF) in SCD correlate with increased plasma levels of ET-1, PAI-1, and other physiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonsalves, Caryn S., Li, Chen, Malik, Punam, Tahara, Stanley M., Kalra, Vijay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672349/
https://www.ncbi.nlm.nih.gov/pubmed/26460070
http://dx.doi.org/10.1042/BSR20150190
_version_ 1782404553929392128
author Gonsalves, Caryn S.
Li, Chen
Malik, Punam
Tahara, Stanley M.
Kalra, Vijay K.
author_facet Gonsalves, Caryn S.
Li, Chen
Malik, Punam
Tahara, Stanley M.
Kalra, Vijay K.
author_sort Gonsalves, Caryn S.
collection PubMed
description Endothelin-1 (ET-1) and plasminogen activator inhibitor-1 (PAI-1) play important roles in pulmonary hypertension (PH) in sickle cell disease (SCD). Our previous studies show higher levels of placenta growth factor (PlGF) in SCD correlate with increased plasma levels of ET-1, PAI-1, and other physiological markers of PH. PlGF-mediated ET-1 and PAI-1 expression occurs via activation of hypoxia-inducible factor-1α (HIF-1α). However, relatively little is understood regarding post-transcriptional regulation of PlGF-mediated expression of ET-1 and PAI-1. Herein, we show PlGF treatment of endothelial cells reduced levels of miR-301a and miR-454 from basal levels. In addition, both miRNAs targeted the 3′-UTRs of ET-1 and PAI-1 mRNAs. These results were corroborated in the mouse model of SCD [Berkeley sickle mice (BK-SS)] and in SCD subjects. Plasma levels of miR-454 in SCD subjects were significantly lower compared with unaffected controls, which correlated with higher plasma levels of both ET-1 and PAI-1. Moreover, lung tissues from BK-SS mice showed significantly reduced levels of pre-miR-301a and concomitantly higher levels of ET-1 and PAI-1. Furthermore, we show that miR-301a/miR-454 located in the spindle and kinetochore-associated protein-2 (SKA2) transcription unit was co-transcriptionally regulated by both HIF-1α and peroxisome proliferator-activated receptor-α (PPAR-α) as demonstrated by SKA2 promoter mutational analysis and ChIP. Finally we show that fenofibrate, a PPAR-α agonist, increased the expression of miR-301a/miR-454 and SKA2 in human microvascular endothelial cell line (HMEC) cells; the former were responsible for reduced expression of ET-1 and PAI-1. Our studies provide a potential therapeutic approach whereby fenofibrate-induced miR-301a/miR-454 expression can ameliorate PH and lung fibrosis by reduction in ET-1 and PAI-1 levels in SCD.
format Online
Article
Text
id pubmed-4672349
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-46723492015-12-17 Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease Gonsalves, Caryn S. Li, Chen Malik, Punam Tahara, Stanley M. Kalra, Vijay K. Biosci Rep Original Papers Endothelin-1 (ET-1) and plasminogen activator inhibitor-1 (PAI-1) play important roles in pulmonary hypertension (PH) in sickle cell disease (SCD). Our previous studies show higher levels of placenta growth factor (PlGF) in SCD correlate with increased plasma levels of ET-1, PAI-1, and other physiological markers of PH. PlGF-mediated ET-1 and PAI-1 expression occurs via activation of hypoxia-inducible factor-1α (HIF-1α). However, relatively little is understood regarding post-transcriptional regulation of PlGF-mediated expression of ET-1 and PAI-1. Herein, we show PlGF treatment of endothelial cells reduced levels of miR-301a and miR-454 from basal levels. In addition, both miRNAs targeted the 3′-UTRs of ET-1 and PAI-1 mRNAs. These results were corroborated in the mouse model of SCD [Berkeley sickle mice (BK-SS)] and in SCD subjects. Plasma levels of miR-454 in SCD subjects were significantly lower compared with unaffected controls, which correlated with higher plasma levels of both ET-1 and PAI-1. Moreover, lung tissues from BK-SS mice showed significantly reduced levels of pre-miR-301a and concomitantly higher levels of ET-1 and PAI-1. Furthermore, we show that miR-301a/miR-454 located in the spindle and kinetochore-associated protein-2 (SKA2) transcription unit was co-transcriptionally regulated by both HIF-1α and peroxisome proliferator-activated receptor-α (PPAR-α) as demonstrated by SKA2 promoter mutational analysis and ChIP. Finally we show that fenofibrate, a PPAR-α agonist, increased the expression of miR-301a/miR-454 and SKA2 in human microvascular endothelial cell line (HMEC) cells; the former were responsible for reduced expression of ET-1 and PAI-1. Our studies provide a potential therapeutic approach whereby fenofibrate-induced miR-301a/miR-454 expression can ameliorate PH and lung fibrosis by reduction in ET-1 and PAI-1 levels in SCD. Portland Press Ltd. 2015-12-08 /pmc/articles/PMC4672349/ /pubmed/26460070 http://dx.doi.org/10.1042/BSR20150190 Text en © 2015 Authors http://creativecommons.org/licenses/by/3.0/ This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0 (http://creativecommons.org/licenses/by/3.0/) .
spellingShingle Original Papers
Gonsalves, Caryn S.
Li, Chen
Malik, Punam
Tahara, Stanley M.
Kalra, Vijay K.
Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease
title Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease
title_full Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease
title_fullStr Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease
title_full_unstemmed Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease
title_short Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell disease
title_sort peroxisome proliferator-activated receptor-α-mediated transcription of mir-301a and mir-454 and their host gene ska2 regulates endothelin-1 and pai-1 expression in sickle cell disease
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672349/
https://www.ncbi.nlm.nih.gov/pubmed/26460070
http://dx.doi.org/10.1042/BSR20150190
work_keys_str_mv AT gonsalvescaryns peroxisomeproliferatoractivatedreceptoramediatedtranscriptionofmir301aandmir454andtheirhostgeneska2regulatesendothelin1andpai1expressioninsicklecelldisease
AT lichen peroxisomeproliferatoractivatedreceptoramediatedtranscriptionofmir301aandmir454andtheirhostgeneska2regulatesendothelin1andpai1expressioninsicklecelldisease
AT malikpunam peroxisomeproliferatoractivatedreceptoramediatedtranscriptionofmir301aandmir454andtheirhostgeneska2regulatesendothelin1andpai1expressioninsicklecelldisease
AT taharastanleym peroxisomeproliferatoractivatedreceptoramediatedtranscriptionofmir301aandmir454andtheirhostgeneska2regulatesendothelin1andpai1expressioninsicklecelldisease
AT kalravijayk peroxisomeproliferatoractivatedreceptoramediatedtranscriptionofmir301aandmir454andtheirhostgeneska2regulatesendothelin1andpai1expressioninsicklecelldisease